Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think someone is forcing the price down so they can get the shares and get the people selling out. I hope I’m right. I’m still holding.
I see what’s happening. Someone is accumulating. There are only 75,000 shares out there. Someone owns about 25% at this point.
The Ask is now below $1. What a pile of S*it! Management should be ashamed of themselves. Why did they go to all this trouble and then not complete the merger?
BUX
I'm with you. Still buying as I have dry powder. This isn't dead by any means. In fact, it provides Asians with a super buying op and they are probably waiting for the final capitulation as well.
I guess if it goes back to that price post RS, I’ll just buy the whole damn float and average down.
Where’s the crying emoji?
This will most likely go down with no buyers at all. This is .005 pre RS and nothing!
Loke is a POS!
I threw my shares up on 1.55 to be funny. Pulled them off hoping you other 2 assholes would do the same.
Wait. What? What made you think that CSTI will Short it?
Looks like CSTI is going to short this now! Highly doubt anyone thinks they could flip this quick for $300.00 with that many shares lol
I bought a lot more down here for that very reason. There could be some big surprises in the Asian market
I’ll say this. I’m holding it for when someone buys the Shell from Loke. At this point, that’s the profitable move.
Fuuuuh, been stuck forever.
This thing is done as no one even wants the equivalent of .008 per share on the ask.
Great job Loke you drunk.
They are fun to watch and, being in the film industry, they are well made.
No, I've not heard, nor have I gotten through.
I've reread all the info I can get my hands on and am convinced that something's up.
I'm buying all I can afford down here at these bargain basement prices. Run out of powder at the moment.
I won't suggest or speculate anything except that I've a hunch that they're not going to waste our time OR especially their own.
Anybody figure out anything yet?
At the number that I called, they did not. What number did you call?
I called and get a representative who answers. They said “Hello” so I take it they speak English
They like their owns posts for enabling asia and buzzme but they won’t answer shareholders...
https://www.facebook.com/321880117890678/posts/1906557036089637/
https://www.facebook.com/102564753234238/posts/1052854171538620/
I’m going to try Monday. Also going to try calling one of those tech magazines. See if I can get an editor or a tech geek.
That can’t be good. I don’t speak Malaysian, but I did try calling over there.
Loke and his band of merry enabler‘s has completely disappeared. There’s not a mention of enabling Asia anywhere in Malaysia or Thailand in any news article nor can I get anybody to say anything. Of course I haven’t called over there so I guess that’s the next step.
You still holding your shares? Or did you dump?
If anyone was a shareholder of EAIN prior to the reverse split last fall the PPS equivalent today 0.004.
WHAT A BEAUTY! A typical Arcaro scam running amuck on the OTC.
Going to zero... Get out while you can.... JMVHO.
They haven’t come after me yet. $eain
lol. I can’t imagine how many shares you must have now. Do you have to report to the SEC as majority owner yet? I have an order for 75,000 shares at .01 if anybody wants to dump that low.
I wish their stream were just a little bit stronger and P down to that $1.25 bid.
Can’t wait for the pissing match to stop.
If I were the CEO, I’d swipe those 2500 along with the other 2500 that have gone the last couple of days. Someone new now has almost 10% of the float.
Lol!!!! I was wondering if you grabbed them. Good timing, man. Literally was clicking to buy myself and they were gone.
Low, low, low hanging fruit... $2.20??? Wow. Hope the seller has an opportunity staring them in the face with the few thou they scooped up.
I'll admit I did afford a portion of them.
Alright. I admit it. A little annoyed that I didn’t get them.
Dammit! I was about to slap the 2.20s and someone wiped them out. Smh.
Well played whoever just did that. Well played.
I know, right? That was cheap af.
I wish I had them. Holy dump ‘em Batpoop.
And someone smacked 2.20 on the ask for 500 shares.
WOW. Someone just dumped 2500 shares. AND someone just bought 2500 shares. Insane.
Only article I see on them...
After Reaching Milestone, Is ENABLING ASIA INC (OTCMKTS:EAIN)’s Short Interest Revealing Something?
July 2, 2018 - By Carolyn Hewitt
The stock of ENABLING ASIA INC (OTCMKTS:EAIN) registered an increase of 75% in short interest. EAIN’s total short interest was 700 shares in July as published by FINRA. Its up 75% from 400 shares, reported previously. With 100 shares average volume, it will take short sellers 7 days to cover their EAIN’s short positions.
It closed at $2.81 lastly. It is down 0.00% since July 2, 2017 and is . It has underperformed by 12.57% the S&P500.
May 25, 2018 - By Adrian Mccoy
The stock of ENABLING ASIA INC (OTCMKTS:EAIN) registered an increase of 75% in short interest. EAIN’s total short interest was 700 shares in May as published by FINRA. Its up 75% from 400 shares, reported previously. With 100 shares average volume, it will take short sellers 7 days to cover their EAIN’s short positions.
It closed at $4.26 lastly. It is down 0.00% since May 25, 2017 and is . It has underperformed by 11.55% the S&P500.
Enabling Asia, Inc., a development stage company, focuses on developing and operating Internet domain names in the budget travel and related categories. The company has market cap of $247,280. The firm was formerly known as Budget Center Inc. and changed its name to Budget Center Inc. in November 2017. It currently has negative earnings.
http://thecasualsmart.com/2018/07/02/after-reaching-milestone-is-enabling-asia-inc-otcmktseains-short-interest-revealing-something/
Then there’s google:
SecureWare
Bank
enablingasia.com
SecureWare Inc., founded in 1986 developed software and encryption technology for securing Unix-based operating systems. Its secure operating system was used to help secure the world's first internet bank, Security First Network Bank. Wikipedia
Stock price: EAIN (OTCMKTS) $2.81 0.00 (0.00%)
Jun 27, 4:00 PM EDT - Disclaimer
Founded: 1986
Subsidiaries: Money House Financial Services Inc., Vericard Inc.
Feedback
Do you manage the online presence for SecureWare?
https://g.co/kgs/X8xFNW
Guessing nobody has seen anything from the company either?
Filings should be due.
Thank you. I thought the same.
What are you talking about? FINRA approved the ticker name change from $BDGN/D to $EAIN....
1Q 18 financials should be coming through soon. If they request for an extension then we will have to wait after June to see them, but everything still seems to be going on track.
The website and the operating company are irrelevant unless and until they merge it into the EAIN shell, which there is no sign that they have done.
Anyone know when the next SEC filing is due?
You know what would be a good sign? If somebody took those 9000 shares. :)
It’s not dead any more. They got the site back up today.
EnablingAsia.com is back up.
Yup... It’s been dead for more than a month...
No updates, no responses to company social media, company emails, or phone calls...
Suddenly their FB has new website... and all posts even back to beginning of year have new contact info...
https://www.facebook.com/321880117890678/posts/1906566969421977/
https://www.facebook.com/102564753234238/posts/1052856921538345/
But twitter accounts still dead...
#enabalingasia website is live now, visit http://t.co/SgfpWB83
— EnablingAsia (@enablingasiaMYS) May 23, 2012
Ok great, good find......
OTC Markets had their website as www.enablingasia.com . That link is dead/suspended.
Well the website is not working BUT the number is still INSV. Since they are still answering the phones then it could be as simple as revamping a whole new website. Well talks around here say they may be merging hmmmm, so why still have an enablingasia website.
Also EAIN promptly delivered eoy results thereby burying BDGN on March 19th. Lets see if there is a method to the madness tomorrow June 19th.
It's a POS dead shell. Loke cant climb out of the bottle long enough to even fix the website let alone complete the merger or put out news.
Enablingasia.com is suspended.
Followers
|
58
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4425
|
Created
|
11/19/09
|
Type
|
Free
|
Moderators |
JERUSALEM and PHOENIX, June 23, 2020 /PRNewswire/ -- Mirror Biologics, Inc. (Phoenix, AZ), the commercial development arm of Immunovative Therapies, Ltd. (Jerusalem, IL) (together "the Company"), a clinical-stage company specialized in the development, manufacturing and clinical translation of next-generation immunotherapy drugs where the active ingredients are living immune cells, today announced that the U.S. Food and Drug Administration (FDA) has cleared our Phase I/II universal virus vaccine clinical trial under the Company's second active Investigational New Drug (IND) application enabling use of the Company's lead experimental drug, AlloStim®, for testing as an anti-viral prophylaxis drug.
AlloStim® is an off-the-shelf, non-genetically manipulated, patented living immune cell with multiple immunodulatory properties, currently being tested under a separate IND as a therapeutic vaccine for chemotherapy-refractory metastatic cancers.
This Phase I/II trial is believed to be the first anti-viral vaccine in clinical development that is specifically targeted to protect the elderly. The elderly are the most vulnerable in our society to the severe and lethal effects of respiratory viral infections which cause disease complications such as pneumonia. Pneumonia is the single most common cause of death from infectious disease in those over 65 years old. The chance that a COVID-19 patient will develop symptoms severe enough to require hospitalization and respiratory support rises sharply with age and the death rate due to COVID-19 is disproportionately higher in our senior citizens.
Dr. Michael Har-Noy, founder and CEO stated: "We are pleased to have FDA clearance of our novel universal viral vaccine clinical trial targeted to healthy adults over 65 years old. There is a large unmet need to protect the elderly from the devastating effects of respiratory viral infection. If we can protect the elderly from COVID-19, economies can open safely and herd immunity can be allowed to develop without an alarming increase in death rate. Even if a COVID-19 vaccine is developed, it is likely, as with influenza vaccines, that it will be less effective in the elderly where protection is most needed. In addition, a successful COVID-19 vaccine is vulnerable to weakening upon mutation of the virus and will not protect against future novel viral outbreaks. Our universal vaccine technology is designed to protect against any type of viral infection without the requirement to have prior knowledge of the viral structure and is specifically designed to work in the weakened senescent immune systems of the elderly and frail."
The Phase I/II clinical trial will accrue 40 healthy adults over age 65. Volunteers will receive five (5) intradermal injections of AlloStim® over 14 days. Blood samples will be collected prior to injection and at 30 days, 6 months and 1 year after injection. The blood will be challenged in the laboratory with a panel of live viruses, including the COVID-19 virus and influenza viruses in order to determine if the remodeled immune system can suppress the propagation of these viruses in cultures of human endothelial cells from the respiratory tract.
Details of the clinical trial can be found on the National Institutes of Health ClinicalTrials.gov registry: ClinicalTrials.gov Identifier: NCT04441047
The universal viral protection mechanism has been reversed engineered from the immune response that results in asymptomatic viral clearance in youthful individuals. Using a novel, patent-pending technology called "allo-priming", the youthful immune response is imprinted upon the elderly immune system so that it can be ready to be activated upon encounter with any virus. The mechanism creates conditions for an "in-situ" vaccine providing viral-specific protection and memory to prevent re-infection from the same virus. The novel mechanism has been described in a peer-reviewed article published in the Journal of Translational Medicine which can be viewed by following this link.
AlloStim® is derived from precursor cells purified from the blood of healthy donors. The Company will be working to scale up and automate the production process in parallel with on-going clinical trials so that upon demonstration of safety and efficacy, the vaccine can be quickly scaled-up to quantities necessary to protect the elderly population. Today, there is estimated to be more than 46 million adults age 65 and older living in the USA.
Media Contact:
Dr. Michael Har-Noy
Phone: 1-760-216-7494
email: harnoy@immunovative.com
Related Images
Mirror Biologics
Mirror Biologics, Inc (Phoenix) is the commercial development arm of Immunovative Therapies, Ltd. (Israel)
Related Links
SOURCE Immunovative Therapies, Ltd.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |